Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brain Cancer
Data on TaqMan MicroRNA Assay for human brain cancer samples were presented
June 6th, 2005
Applied Biosystems Group (ABI), an Applera Corporation business, and Dartmouth Medical School presented data using a preliminary version of Applied Biosystems TaqMan MicroRNA (miRNA) Assays to profile microRNA expression in human brain cancer samples. MiRNAs are a recently discovered class of small RNA molecules known to play a powerful gene regulatory role in cell differentiation, developmental biology, cancer, and other diseases. The collaborative research study examined the role of miRNAs in glioblastoma multiforme, an aggressive form of brain cancer. Comparison of miRNA expression profiles between normal human brain and glioblastoma brain tumors...
Source: Biotech Business Week (2005-06-06)
|
